Shoulder Innovations, Inc. (SI) stock
SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3052% above fair value
$20.69−0.39 (-1.85%)
Close on Nov 13, 2026Market cap $430.74MP/E –Yield –
Shoulder Innovations r&d expenses
Research and development expenses are spending on new products and technology.
Shoulder Innovations's R&D Expenses for the twelve months ending Sep 30, 2026 was $13.53M, up 138.1% year over year. For fiscal 2025 it was $7.73M, up 72.2% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.73M | +72.2% |
| FY2024 | Dec 31, 2024 | $4.49M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.17M | +107.5% |
| Q2 FY2026 | Jun 30, 2026 | $3.39M | +141.2% |
| Q1 FY2026 | Mar 31, 2026 | $3.75M | +137.1% |
| Q4 FY2025 | Dec 31, 2025 | $3.22M | +175.7% |
| Q3 FY2025 | Sep 30, 2025 | $1.53M | +39.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.41M | +21.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.58M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.17M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.09M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.16M | – |
See a number that looks wrong?